Addressing unmet medical needs.
Joint Research
U-Factor Co., Ltd. is collaborating with the National Institute of Advanced Industrial Science and Technology and Keio University to develop innovative treatments using cutting-edge regenerative medicine technologies. Our research aims to maximize the effectiveness of stem cell-derived culture supernatant and provide safe and effective new therapies. Through this collaboration, we expect to develop treatments that offer effects comparable to stem cell transplantation, improving patients' quality of life. In the future, we aim to provide innovative medical solutions to more people based on these research outcomes.
